• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活物调节缺血性脑内的葡萄糖摄取。

Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain.

机构信息

Department of Neurology and Center for Neurodegenerative Disease, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

出版信息

J Neurosci. 2012 Jul 18;32(29):9848-58. doi: 10.1523/JNEUROSCI.1241-12.2012.

DOI:10.1523/JNEUROSCI.1241-12.2012
PMID:22815500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3437989/
Abstract

The ability to sense and adapt to hypoxic conditions plays a pivotal role in neuronal survival. Hypoxia induces the release of tissue-type plasminogen activator (tPA) from cerebral cortical neurons. We found that the release of neuronal tPA or treatment with recombinant tPA promotes cell survival in cerebral cortical neurons previously exposed to hypoxic conditions in vitro or experimental cerebral ischemia in vivo. Our studies using liquid chromatography and tandem mass spectrometry revealed that tPA activates the mammalian target of rapamycin (mTOR) pathway, which adapts cellular processes to the availability of energy and metabolic resources. We found that mTOR activation leads to accumulation of the hypoxia-inducible factor-1α (HIF-1α) and induction and recruitment to the cell membrane of the HIF-1α-regulated neuronal transporter of glucose GLUT3. Accordingly, in vivo positron emission tomography studies with 18-fluorodeoxyglucose in mice overexpressing tPA in neurons show that neuronal tPA induces the uptake of glucose in the ischemic brain and that this effect is associated with a decrease in the volume of the ischemic lesion and improved neurological outcome following the induction of ischemic stroke. Our data indicate that tPA activates a cell signaling pathway that allows neurons to sense and adapt to oxygen and glucose deprivation.

摘要

感知和适应缺氧环境的能力在神经元存活中起着关键作用。缺氧诱导脑皮质神经元释放组织型纤溶酶原激活物(tPA)。我们发现,神经元 tPA 的释放或用重组 tPA 处理可促进体外先前暴露于缺氧条件或体内实验性脑缺血的脑皮质神经元的细胞存活。我们使用液相色谱和串联质谱的研究表明,tPA 激活了雷帕霉素靶蛋白(mTOR)途径,该途径使细胞过程适应能量和代谢资源的可用性。我们发现 mTOR 激活导致缺氧诱导因子-1α(HIF-1α)的积累,并诱导和募集到 HIF-1α 调节的神经元葡萄糖转运蛋白 GLUT3 的细胞膜上。因此,在过表达神经元 tPA 的小鼠的体内正电子发射断层扫描研究中,用 18-氟脱氧葡萄糖进行示踪,结果显示神经元 tPA 诱导缺血脑内葡萄糖摄取,并且这种作用与缺血性损伤体积减小以及诱导缺血性中风后神经功能结局改善相关。我们的数据表明,tPA 激活了一种细胞信号通路,使神经元能够感知和适应缺氧和葡萄糖剥夺。

相似文献

1
Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain.组织型纤溶酶原激活物调节缺血性脑内的葡萄糖摄取。
J Neurosci. 2012 Jul 18;32(29):9848-58. doi: 10.1523/JNEUROSCI.1241-12.2012.
2
Tissue-type plasminogen activator mediates neuronal detection and adaptation to metabolic stress.组织型纤溶酶原激活物介导神经元对代谢应激的检测和适应。
J Cereb Blood Flow Metab. 2013 Nov;33(11):1761-9. doi: 10.1038/jcbfm.2013.124. Epub 2013 Jul 24.
3
Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.组织型纤溶酶原激活物介导中枢神经系统中的神经胶质偶联。
Neuroscience. 2014 Jan 17;257:41-8. doi: 10.1016/j.neuroscience.2013.10.060. Epub 2013 Nov 4.
4
Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.组织型纤溶酶原激活剂是中枢神经系统中的一种神经保护剂。
Front Cell Neurosci. 2015 Aug 17;9:304. doi: 10.3389/fncel.2015.00304. eCollection 2015.
5
tPA promotes cortical neuron survival via mTOR-dependent mechanisms.组织型纤溶酶原激活剂(tPA)通过mTOR依赖的机制促进皮质神经元存活。
Mol Cell Neurosci. 2016 Jul;74:25-33. doi: 10.1016/j.mcn.2016.03.005. Epub 2016 Mar 16.
6
Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.组织型纤溶酶原激活物通过神经元 TNF-α 在缺血性脑中发挥神经保护作用。
J Cereb Blood Flow Metab. 2012 Jan;32(1):57-69. doi: 10.1038/jcbfm.2011.106. Epub 2011 Jul 27.
7
Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.神经丝氨酸蛋白酶抑制剂通过抑制组织型纤溶酶原激活物独立地保护神经元免受缺血诱导的纤维蛋白溶酶介导的细胞死亡。
Am J Pathol. 2010 Nov;177(5):2576-84. doi: 10.2353/ajpath.2010.100466. Epub 2010 Sep 23.
8
Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen.实验性局灶性脑缺血后持续的神经元丢失不受组织型纤溶酶原激活物和高压氧联合给药的影响。
Brain Res. 2011 Oct 12;1417:115-26. doi: 10.1016/j.brainres.2011.08.024. Epub 2011 Aug 22.
9
Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an model of ischemic stroke.在缺血性中风模型中,异氟烷预处理可抑制组织型纤溶酶原激活剂对脑内皮细胞的作用。
Int J Med Sci. 2017 Apr 8;14(5):425-433. doi: 10.7150/ijms.18037. eCollection 2017.
10
Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia.PLAT/tPA 溶栓会增加血清游离 IGF1,从而减少脑缺血后有害的自噬。
Autophagy. 2022 Jun;18(6):1297-1317. doi: 10.1080/15548627.2021.1973339. Epub 2021 Sep 14.

引用本文的文献

1
The Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons.内源性神经元 tPA 的双面性:促进自我保护和加重邻近神经元死亡。
Cell Death Dis. 2024 Apr 12;15(4):261. doi: 10.1038/s41419-024-06655-0.
2
Glucocorticoid-Responsive Tissue Plasminogen Activator (tPA) and Its Inhibitor Plasminogen Activator Inhibitor-1 (PAI-1): Relevance in Stress-Related Psychiatric Disorders.糖皮质激素反应性组织纤溶酶原激活物(tPA)及其抑制剂纤溶酶原激活物抑制剂-1(PAI-1):与应激相关精神障碍的相关性。
Int J Mol Sci. 2023 Feb 24;24(5):4496. doi: 10.3390/ijms24054496.
3
NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease.NMDA 受体 C 端结构域在发育、成熟和疾病中的信号转导。
Int J Mol Sci. 2022 Sep 27;23(19):11392. doi: 10.3390/ijms231911392.
4
Parvalbumin interneuron-derived tissue-type plasminogen activator shapes perineuronal net structure.钙结合蛋白阳性中间神经元衍生的组织型纤溶酶原激活物塑造周围神经毡的结构。
BMC Biol. 2022 Oct 5;20(1):218. doi: 10.1186/s12915-022-01419-8.
5
Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival.双链组织型纤溶酶原激活物统一代谢型谷氨酸受体和 NMDA 受体信号转导以控制神经元存活。
Int J Mol Sci. 2021 Dec 15;22(24):13483. doi: 10.3390/ijms222413483.
6
Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia.PLAT/tPA 溶栓会增加血清游离 IGF1,从而减少脑缺血后有害的自噬。
Autophagy. 2022 Jun;18(6):1297-1317. doi: 10.1080/15548627.2021.1973339. Epub 2021 Sep 14.
7
Involvement of glucose transporter overexpression in the protection or damage after ischemic stroke.葡萄糖转运体过表达在缺血性脑卒中后的保护或损伤中的作用。
Neural Regen Res. 2022 Apr;17(4):783-784. doi: 10.4103/1673-5374.322456.
8
Research Progress on the Mechanism of Mitochondrial Autophagy in Cerebral Stroke.脑卒中线粒体自噬机制的研究进展
Front Aging Neurosci. 2021 Jul 15;13:698601. doi: 10.3389/fnagi.2021.698601. eCollection 2021.
9
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.神经血管和神经退行性疾病中的纤溶酶原激活剂
Int J Mol Sci. 2021 Apr 22;22(9):4380. doi: 10.3390/ijms22094380.
10
Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.尿激酶型纤溶酶原激活物促进缺血性脑内 N-钙黏蛋白介导电突触恢复。
J Cereb Blood Flow Metab. 2021 Sep;41(9):2381-2394. doi: 10.1177/0271678X211002297. Epub 2021 Mar 24.

本文引用的文献

1
Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.组织型纤溶酶原激活物通过神经元 TNF-α 在缺血性脑中发挥神经保护作用。
J Cereb Blood Flow Metab. 2012 Jan;32(1):57-69. doi: 10.1038/jcbfm.2011.106. Epub 2011 Jul 27.
2
Activity-dependent regulation of surface glucose transporter-3.活动依赖性调节表面葡萄糖转运蛋白-3。
J Neurosci. 2011 Feb 9;31(6):1991-9. doi: 10.1523/JNEUROSCI.1850-09.2011.
3
PTEN deletion prevents ischemic brain injury by activating the mTOR signaling pathway.PTEN 缺失通过激活 mTOR 信号通路来防止缺血性脑损伤。
Biochem Biophys Res Commun. 2011 Jan 28;404(4):941-5. doi: 10.1016/j.bbrc.2010.12.085. Epub 2010 Dec 23.
4
Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.神经丝氨酸蛋白酶抑制剂通过抑制组织型纤溶酶原激活物独立地保护神经元免受缺血诱导的纤维蛋白溶酶介导的细胞死亡。
Am J Pathol. 2010 Nov;177(5):2576-84. doi: 10.2353/ajpath.2010.100466. Epub 2010 Sep 23.
5
Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves.哺乳动物雷帕霉素靶蛋白(mTOR)的激活增加了受损周围神经的轴突生长能力。
J Biol Chem. 2010 Sep 3;285(36):28034-43. doi: 10.1074/jbc.M110.125336. Epub 2010 Jul 8.
6
Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.组织型纤溶酶原激活物是小鼠海马中的一种神经保护剂。
J Clin Invest. 2010 Jun;120(6):2194-205. doi: 10.1172/JCI41722. Epub 2010 May 3.
7
Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.TMEM127 种系突变可导致嗜铬细胞瘤易感性。
Nat Genet. 2010 Mar;42(3):229-33. doi: 10.1038/ng.533. Epub 2010 Feb 14.
8
BDNF function and intracellular signaling in neurons.BDNF 的功能和神经元中的细胞内信号转导。
Histol Histopathol. 2010 Feb;25(2):237-58. doi: 10.14670/HH-25.237.
9
Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.缺氧诱导因子 1 作为缺血性脑卒中的治疗靶点。
Curr Med Chem. 2009;16(34):4593-600. doi: 10.2174/092986709789760779.
10
HIF-1 alpha-deficient mice have increased brain injury after neonatal hypoxia-ischemia.缺氧诱导因子-1α缺陷型小鼠在新生期缺氧缺血后脑损伤增加。
Dev Neurosci. 2009;31(5):452-8. doi: 10.1159/000232563. Epub 2009 Aug 11.